Coverage
-
February 14, 2023
A proposed class of CBD supplement buyers is again asking a California federal court to reopen its claims alleging CV Sciences Inc. illegally sold CBD products as dietary supplements, saying a recent announcement from the U.S. Food and Drug Administration means there's no reason for further delay.
7 other articles on this case.
View all »